Marc A Lerner

Title(s)Recall Faculty, Pediatrics
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(657) 579-4100
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Multistage Adolescent Depression Screening: A Comparison of 11-Year-Olds to 12-Year-Olds. Perm J. 2021 05; 25. Cortez AB, Wilkins J, Handler E, Lerner MA, Burchette R, Wissow LS. PMID: 33970080; PMCID: PMC8784043.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    2. School Readiness. Pediatrics. 2019 08; 144(2). Williams PG, Lerner MA, COUNCIL ON EARLY CHILDHOOD, COUNCIL ON SCHOOL HEALTH. PMID: 31331984.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    3. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017 Jun; 58(6):663-678. Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC, MTA Cooperative Group. PMID: 28295312; PMCID: PMC6168061.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    4. Prevalence and Characteristics of School Services for High School Students with Attention-Deficit/Hyperactivity Disorder. School Ment Health. 2014 Dec 01; 6(4):264-278. Murray DW, Molina BS, Glew K, Houck P, Greiner A, Fong D, Swanson J, Arnold LE, Lerner M, Hechtman L, Abikoff HB, Jensen PS. PMID: 25506403; PMCID: PMC4261048.
      View in: PubMed   Mentions: 10  
    5. Prevalence of ADHD symptoms in patients with congenital heart disease. Pediatr Int. 2012 Dec; 54(6):838-43. Hansen E, Poole TA, Nguyen V, Lerner M, Wigal T, Shannon K, Wigal SB, Batra AS. PMID: 22882233.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    6. Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate. J Child Adolesc Psychopharmacol. 2012 Apr; 22(2):149-56. Wigal SB, Wong AA, Jun A, Stehli A, Steinberg-Epstein R, Lerner MA. PMID: 22372513.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    7. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate? Postgrad Med. 2010 Sep; 122(5):27-34. Wigal SB, Jun A, Wong AA, Stehli A, Steinberg-Epstein R, Lerner MA. PMID: 20861585.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    8. Long-term safety of stimulant medications used to treat children with ADHD. J Psychosoc Nurs Ment Health Serv. 2008 Aug; 46(8):38-48. Lerner M, Wigal T. PMID: 18777967.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008 Jul; 12(1):4-14. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T, MTA Cooperative Group. PMID: 18573923.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    10. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord. 2008 Jul; 12(1):15-43. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T, MTA Cooperative Group. PMID: 18573924.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    11. Long-term safety of stimulant medications used to treat children with ADHD. Pediatr Ann. 2008 Jan; 37(1):37-45. Lerner M, Wigal T. PMID: 18240852.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Pediatrics. 2007 Jul; 120(1):e120-8. Wigal SB, Wilens TE, Wolraich M, Lerner M. PMID: 17548486.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Apr; 17(2):153-64. Wigal SB, Gupta S, Greenhill L, Posner K, Lerner M, Steinhoff K, Wigal T, Kapelinski A, Martinez J, Modi NB, Stehli A, Swanson J. PMID: 17489710.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    14. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):351-6. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M. PMID: 16768642.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    15. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry. 2006 May; 45(5):527-537. Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B, CONCERTA STUDY GROUP. PMID: 16670649.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    16. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006 Jan; 160(1):82-90. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. PMID: 16389216.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    17. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1015-23. Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. PMID: 16175106.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    18. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. J Clin Psychopharmacol. 2004 Feb; 24(1):36-41. Wilens TE, Biederman J, Lerner M, Concerta Study Group. PMID: 14709945.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    19. A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder. J Urol. 2003 Oct; 170(4 Pt 2):1521-3; discussion 1523-4. Duel BP, Steinberg-Epstein R, Hill M, Lerner M. PMID: 14501650.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    20. A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003 Oct; 42(10):1234-41. Greenhill LL, Swanson JM, Steinhoff K, Fried J, Posner K, Lerner M, Wigal S, Clausen SB, Zhang Y, Tulloch S. PMID: 14560174.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    21. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003 Feb; 60(2):204-11. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. PMID: 12578439.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    22. Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry. 2002 Nov; 41(11):1306-14. Swanson JM, Gupta S, Williams L, Agler D, Lerner M, Wigal S. PMID: 12410072.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    Marc's Networks
    Concepts (97)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California